Moreover, before chemotherapy, the patients have more APE1-AAbs in their peripheral blood indicating that more APE1 protein is present in tumor tissues compared to normal tissue, thereby leading to resistance to platinum-based treatment. The gene discussed is APEX1; the disease is neoplasm.